Purchase Agreement


 Exhibit 10.36 
  
 Conformed Copy 
  
 $250,000,000 
  
 BLACKROCK, INC. 
  
 2.625% Convertible Debentures Due 2035 
  
 PURCHASE
AGREEMENT 
  
 February 16, 2005 
  








 Exhibit 10.36 
  
 SCHEDULE A 
  
 The following table sets forth the hypothetical stock price and the number of Additional Shares to be issuable per $1,000 principal amount of Debentures:

  

																															
	 	  	Stock Price


	 Effective Date

	  	$77.58

	  	$85.00

	  	$90.00

	  	$95.00

	  	$100.00

	  	$105.00

	  	$110.00

	  	$115.00

	  	$120.00

	  	$130.00

	  	150.00

	  	$175.00

	  	$200.00

	  	$250.00

	  	$300.00


	 February 23, 2005
	  	3.16	  	2.45	  	2.08	  	1.77	  	1.52	  	1.31	  	1.13	  	0.99	  	0.87	  	0.68	  	0.46	  	0.31	  	0.23	  	0.15	  	0.10
	 February 15, 2006
	  	3.05	  	2.32	  	1.93	  	1.62	  	1.36	  	1.16	  	0.99	  	0.85	  	0.73	  	0.56	  	0.36	  	0.24	  	0.18	  	0.12	  	0.08
	 February 15, 2007
	  	2.99	  	2.21	  	1.81	  	1.48	  	1.22	  	1.01	  	0.84	  	0.70	  	0.59	  	0.44	  	0.27	  	0.18	  	0.14	  	0.09	  	0.06
	 February 15, 2008
	  	2.95	  	2.10	  	1.66	  	1.32	  	1.04	  	0.83	  	0.66	  	0.53	  	0.43	  	0.30	  	0.17	  	0.12	  	0.09	  	0.06	  	0.04
	 February 15, 2009
	  	2.97	  	2.00	  	1.50	  	1.10	  	0.80	  	0.58	  	0.42	  	0.30	  	0.22	  	0.14	  	0.08	  	0.06	  	0.05	  	0.03	  	0.02
	 February 15, 2010
	  	3.16	  	2.04	  	1.38	  	0.80	  	0.27	  	—  	  	—  	  	—  	  	—  	  	—  	  	—  	  	—  	  	—  	  	—  	  	—  

  








 Exhibit 10.36 
  
 SCHEDULE B 
  
 BLACKROCK, INC. 
 2.625% Convertible Debentures
Due 2035 
  
 No.
                     
  

							
	 Date

	  	 Principal Amount

	  	Notation Explaining
Principal Amount
Recorded

	  	Authorized Signature
of Trustee or
Custodian


	 	  	 	  	 	  	 
	 	  	 	  	 	  	 
	 	  	 	  	 	  	 
	 	  	 	  	 	  	 
	 	  	 	  	 	  	 

  








 February 16, 2005 
  
 Morgan Stanley & Co. Incorporated 
 Citigroup Global Markets Inc. 
 Merrill Lynch, Pierce, Fenner & Smith Incorporated 
 UBS Securities LLC 
  

	c/o	Morgan Stanley & Co. Incorporated 


	 	1585 Broadway 


	 	New York, New York 10036 

  
 Dear Sirs and Mesdames: 
  
 BlackRock, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several purchasers named in Schedule I hereto (the “Initial Purchasers”) 
  
 $250,000,000 aggregate principal amount of its 2.625% Convertible Debentures
Due 2035 (the “Securities”) to be issued pursuant to the provisions of an Indenture to be dated as of February 23, 2005 (the “Indenture”) between the Company and JPMorgan Chase Bank, N.A., as Trustee (the
“Trustee”). The Securities will be convertible into shares of the Company’s Class A common stock, $0.01 par value (the “Underlying Securities”). 
  
 The Securities and the Underlying Securities will be offered without being registered under the Securities Act of 1933, as
amended (the “Securities Act”), to qualified institutional buyers in compliance with the exemption from registration provided by Rule 144A under the Securities Act. 
  
 The Initial Purchasers and their direct and indirect transferees will be entitled to the benefits of a Registration Rights
Agreement dated the Closing Date (as defined herein) between the Company and the Initial Purchasers (the “Registration Rights Agreement”). 
  
 In connection with the sale of the Securities, the Company has prepared a preliminary offering memorandum (the “Preliminary Memorandum”)
and will prepare a final offering memorandum (the “Final Memorandum” and, with the Preliminary Memorandum, each a “Memorandum”) including or incorporating by reference a description of the terms of the Securities
and the Underlying Securities, the terms of the offering and a description of the Company. As used herein, the term “Memorandum” shall include in each case the documents incorporated by reference therein. The terms
“supplement”, “amendment” and “amend” as used herein with respect to a Memorandum shall include all documents deemed to be incorporated by reference in the Preliminary Memorandum or Final Memorandum
that are filed subsequent to the date of such Memorandum with the Securities and Exchange Commission (the 

  








 
“Commission”) pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”). 
  
 1. Representations and Warranties. The Company represents and warrants
to, and agrees with, you that: 
  
 (a) (i) Each
document, if any, filed or to be filed pursuant to the Exchange Act and incorporated by reference in either Memorandum complied or will comply when so filed in all material respects with the Exchange Act and the applicable rules and regulations of
the Commission thereunder and (ii) the Preliminary Memorandum does not contain and the Final Memorandum, in the form used by the Initial Purchasers to confirm sales and on the Closing Date (as defined in Section 4), will not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, except that the representations and warranties set forth in this
paragraph do not apply to statements or omissions in either Memorandum based upon information relating to any Initial Purchaser furnished to the Company in writing by such Initial Purchaser through you expressly for use therein. 
  
 (b) The Company has been duly incorporated, is validly
existing as a corporation in good standing under the laws of the Delaware, has the corporate power and authority to own or lease its property and to conduct its business as described in each Memorandum and is duly qualified to transact business and
is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified or be in good standing would not have a
material adverse effect on the Company and its subsidiaries, taken as a whole. 
  
 (c) Each subsidiary of the Company listed on Schedule II (the “subsidiaries”) hereto has been duly organized, is validly
existing as a corporation or limited liability company, as the case may be, in good standing under the laws of the jurisdiction of its formation, has the corporate or limited liability company power and authority, as the case may be, to own or lease
its property and to conduct its business as described in each Memorandum and is duly qualified to transact business and is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires
such qualification, except to the extent that the failure to be so qualified or be in good standing would not have a material adverse effect on the Company and its subsidiaries, taken as a whole; all of the issued shares of capital stock or
membership interests, as the case may be, of each subsidiary of the Company have been duly and validly authorized and issued and are owned directly or indirectly by the Company, free and clear of all liens, 

  

 2 







 
encumbrances, equities or claims and the issued shares of capital stock are fully paid and non-assessable. 
  
 (d) This Agreement has been duly authorized, executed and
delivered by the Company. 
  
 (e) The authorized
capital stock of the Company conforms as to legal matters to the description thereof contained in the Final Memorandum. 
  
 (f) The shares of common stock outstanding prior to the issuance of the Securities have been duly authorized and validly issued and are
fully paid and non-assessable. 
  
 (g) The
Securities have been duly authorized by the Company and, when executed and authenticated in accordance with the provisions of the Indenture and delivered to and paid for by the Initial Purchasers in accordance with the terms of this Agreement, will
be valid and binding obligations of the Company, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency or similar laws affecting creditors’ rights generally and general principles of equity, and will be
entitled to the benefits of the Indenture pursuant to which such Securities are to be issued and the Registration Rights Agreement. 
  
 (h) The Underlying Securities issuable upon conversion of the Securities have been duly authorized and reserved and, when issued upon
conversion of the Securities in accordance with the terms of the Securities, will be validly issued, fully paid and non–assessable, and the issuance of the Underlying Securities will not be subject to any preemptive or similar rights.

  
 (i) Each of the Indenture and the
Registration Rights Agreement has been duly authorized, executed and delivered by, and is a valid and binding agreement of, the Company, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency or similar laws affecting
creditors’ rights generally and general principles of equity and except as rights to indemnification and contribution under the Registration Rights Agreement may be limited under applicable law. 
  
 (j) The execution and delivery by the Company of, and the
performance by the Company of its obligations under, this Agreement, the Indenture, the Registration Rights Agreement and the Securities will not contravene any provision of applicable law, statute, rule, regulation, or the certificate of
incorporation or by-laws of the Company or any agreement or other instrument binding upon the Company or any of its subsidiaries that is material to the Company and its subsidiaries, taken as a whole, any 

  

 3 







 
judgment, order or decree of any governmental body, agency, court or self–regulatory organization having jurisdiction over the Company or any
subsidiary, and no filing with or consent, approval, authorization, license or order of, or qualification or registration with, any governmental body, agency or self-regulatory organization is required for the performance by the Company of its
obligations under this Agreement, the Indenture, the Registration Rights Agreement or the Securities, except such as may be required by the securities or Blue Sky laws of the various states or other jurisdictions in connection with the offer and
sale of the Securities and by Federal and state securities laws with respect to the Company’s obligations under the Registration Rights Agreement. 
  
 (k) There has not occurred any material adverse change, or any development involving a prospective material adverse change, in the
financial condition, or in the earnings, business or operations of the Company and its subsidiaries, taken as a whole, from that set forth in the Preliminary Memorandum provided to prospective purchasers of the Securities. 
  
 (l) There are no legal or governmental proceedings, actions,
suits, inquiries or investigations pending or threatened to which the Company or any of its subsidiaries is a party or to which any of the properties of the Company or any of its subsidiaries is subject other than (i) proceedings accurately
described in all material respects in each Memorandum and (ii) proceedings that would not have a material adverse effect on the Company and its subsidiaries, taken as a whole, or on the power or ability of the Company to perform its obligations
under this Agreement, the Indenture, the Registration Rights Agreement or the Securities or to consummate the transactions contemplated by the Final Memorandum. 
  
 (m) The Company and its subsidiaries are in compliance with any and all applicable foreign, federal, state
and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants except where such non-compliance would not, singly or in the aggregate, have
a material adverse effect on the Company and its subsidiaries, taken as a whole. 
  
 (n) The Company is not, and solely after giving effect to the offering and sale of the Securities and the application of the proceeds
thereof as described in the Final Memorandum will not be, required to register as an “investment company” as such term is defined in the Investment Company Act of 1940, as amended (the “1940 Act”). 
  

 4 







 (o) Neither the Company nor any affiliate (as defined in Rule 501(b) of Regulation D
under the Securities Act, an “Affiliate”) of the Company has directly, or through any agent, (i) sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any security (as defined in the Securities Act)
which is or will be integrated with the sale of the Securities in a manner that would require the registration under the Securities Act of the Securities or (ii) offered, solicited offers to buy or sold the Securities by any form of general
solicitation or general advertising (as those terms are used in Regulation D under the Securities Act) or in any manner involving a public offering within the meaning of Section 4(2) of the Securities Act. 
  
 (p) It is not necessary in connection with the offer, sale
and delivery of the Securities to the Initial Purchasers in the manner contemplated by this Agreement to register the Securities under the Securities Act or to qualify the Indenture under the Trust Indenture Act of 1939, as amended. 
  
 (q) The Securities satisfy the requirements set forth in
Rule 144A(d)(3) under the Securities Act. 
  
 (r)
Each of the Company and its subsidiaries owns or possesses, or can acquire on reasonable terms, all adequate patents, patent rights, licenses, inventions, copyrights, know how (including trade secrets and other unpatented and/or unpatentable
proprietary or confidential information, systems or procedures), trademarks, service marks and trade names necessary to carry on the business now operated by them, and neither the Company nor any of its subsidiaries has received any notice of
infringement of or conflict with asserted rights of others with respect to any of the foregoing which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would have a material adverse affect on the Company and
its subsidiaries, taken as a whole. 
  
 (s) The
Company and each of its subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which they are engaged; neither the Company nor
any of its subsidiaries has been refused any insurance coverage sought or applied for; and neither the company nor any of its subsidiaries has any reason to believe that it will not be able to renew its existing insurance coverage as and when such
coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not have a material adverse affect on the Company and its subsidiaries, taken as a whole, except as described in
the Memorandum. 
  

 5 







 (t) The Company and its subsidiaries possess all certificates, authorizations, licenses,
approvals, consents, permits and other authorizations issued by the appropriate federal, state or foreign regulatory authorities necessary to conduct their respective businesses, and neither the Company nor any of its subsidiaries has received any
notice of proceedings relating to the revocation or modification of any such certificate, authorization, licenses, approval, consent, permit or other authorization which, singly or in the aggregate, if the subject of an unfavorable decision, ruling
or finding, would have a material adverse affect on the Company and its subsidiaries, taken as a whole, except as described in the Memorandum. 
  
 (u) The Company and each of its subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance
that (i) transactions are executed in accordance with management’s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting
principles and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at
reasonable intervals and appropriate action is taken with respect to any differences. 
  
 (v) The Company has established and maintained disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14)
that are adequate and effective and designed to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to its chief executive officer and chief financial officer by others within those
entities. 
  
 (w) The consolidated financial
statements incorporated by reference in the Memorandum, together with related schedules and notes, present fairly in all material respects the financial position of the Company and its consolidated subsidiaries at the dates indicated and the
statement of operations and stockholders’ equity and cash flows of the Company and its consolidated subsidiaries for the periods specified, said financials have been prepared in accordance with generally accepted accounting principles
(“GAAP”) applied on a consistent basis throughout the periods involved, except as disclosed therein; and the other financial information and data set forth in the Memorandum present fairly, in all material respects, the information
shown therein and have been compiled on a basis consistent with that of the audited financial statements included or incorporated by reference in the Memorandum. 
  
 (x) The Company and its subsidiaries have good and marketable title in fee simple to all real property and
good and marketable 

  

 6 







 
title to all personal property owned by them which is material to the business of the Company and its subsidiaries, in each case free and clear of all liens,
encumbrances and defects except such as are described in the Memorandum or such as do not materially affect the value of such property and do not interfere with the use made and proposed to be made of such property by the Company and its
subsidiaries; and any real property and buildings held under lease by the Company and its subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made
and proposed to be made of such property and buildings by the Company and its subsidiaries, in each case except as described in the Memorandum. 
  
 (y) Each of BlackRock Advisors, Inc., BlackRock Institutional Management Corporation, BlackRock Financial Management, Inc., BlackRock
(Japan), Inc., BlackRock Capital Management, Inc., BlackRock HPB Management, LLC, State Street Research Management Company, BlackRock Realty Advisors, Inc. and BlackRock International Ltd. (together, the “Investment Adviser
Subsidiaries”) is duly registered as an investment adviser under the Investment Advisers Act of 1940, as amended (the “Advisers Act”) and none of the Investment Adviser Subsidiaries is prohibited by any provision of the
Advisers Act or the 1940 Act, or the respective rules and regulations thereunder, from acting as an investment adviser. The Investment Adviser Subsidiaries are the only direct or indirect subsidiaries of the Company required to be registered as
investment advisers under the Advisers Act. Each of the Investment Adviser Subsidiaries is duly registered, licensed or qualified as an investment adviser in each jurisdiction where the conduct of its business requires such registration and is in
compliance with all federal, state and foreign laws requiring any such registration, licensing or qualification or is subject to no material liability or disability by reason of the failure to be so registered, licensed or qualified in any such
jurisdiction or to be in such compliance. None of the Company or its other direct or indirect subsidiaries is required to be registered, licensed or qualified as an investment adviser under the laws requiring any such registration, licensing or
qualification in any jurisdiction in which it or such other subsidiaries conduct business or is subject to material liability or disability by reason of the failure to be so registered, licensed or qualified. 
  
 (z) Each of BlackRock Investments, Inc. and State Street
Research Investment Services (the “Broker Dealer Subsidiaries”) is duly registered, licensed or qualified as a broker-dealer under the Exchange Act, and under the securities laws of each jurisdiction where the conduct of its
business requires such registration and is in compliance with all federal, state and foreign laws requiring such registration, licensing or 

  

 7 







 
qualification or is subject to no material liability or disability by reason of the failure to be so registered, licensed or qualified in any such
jurisdiction or to be in such compliance. Each of the Broker Dealer Subsidiaries is a member in good standing of NASD and each other self-regulatory organization where the conduct of its business requires such membership. Neither the Company nor any
of the Company’s other direct or indirect subsidiaries is required to be registered, licensed or qualified as a broker-dealer under the laws requiring any such registration, licensing or qualification in any jurisdiction in which it or such
other subsidiaries conduct business or is subject to any material liability or disability by reason of the failure to be so registered, licensed or qualified except where the failure to be so registered, licensed or qualified would not have a
material adverse affect on the Company and its subsidiaries, taken as a whole. 
  
 (aa) Each of the Investment Adviser Subsidiaries and the Broker Dealer Subsidiaries is, has been and will upon consummation of the
transactions contemplated herein be, in compliance with, and each such entity has received no notice of any kind of any violation of, (A) all laws, regulations, ordinances and rules (including those of any non-governmental self-regulatory agencies)
applicable to it or its operations relating to investment advisory or broker-dealer activities, as the case may be, and (B) all other laws, regulations, ordinances and rules applicable to it and its operations, except, in either case, where any
failure to comply with any such law, regulation, ordinance or rule would not have, individually or in the aggregate, a material adverse effect on the Company and its subsidiaries taken as a whole. 
  
 (bb) Each entity for which the Investment Adviser
Subsidiaries acts as investment adviser and, to the best knowledge of the Investment Adviser Subsidiaries, each entity for which the Investment Adviser Subsidiaries acts as sub-adviser and, in each case, which is required to be registered with the
Commission as an investment company under the 1940 Act (a “Fund”) is, and upon consummation of the transactions contemplated herein will be, duly registered with the Commission as an investment company under the 1940 Act and to the
best knowledge of the Company, each Fund has been operated in compliance in all material respects with the applicable provisions of the 1940 Act and the rules and regulations thereunder and to the best knowledge of the Company, there are no facts
with respect to any such Fund that are likely to have a material adverse effect on the Company and its subsidiaries taken as a whole. To the knowledge of the Company, each Fund’s registration statement complies (or, in the case of closed-end
funds, complied at the date thereof) in all material respects with the provisions of the Securities Act, the 1940 Act and the rules and regulations thereunder and does not (or, in the case 

  

 8 







 
of closed-end funds, did not at the date thereof) contain any untrue statement of material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading. 
  
 (cc) Each entity for which an Investment Adviser Subsidiary acts as investment adviser and, to the best knowledge of the Investment Adviser Subsidiaries, each entity for which the Investment Adviser Subsidiary acts as
sub-adviser which entity is not required to be registered with the Commission as an investment company under the 1940 Act (an “Exempt Fund”) is not, and upon consummation of the transactions contemplated herein will not be, required
to register with the Commission as an investment company under the 1940 Act and to the best knowledge of the Company there are no facts with respect to any such Exempt Fund that are likely to have a material adverse effect on the Company and its
subsidiaries taken as a whole. To the best knowledge of the Company, each Exempt Fund’s offering documents comply in all material respects with the provisions of the laws applicable to such offering and do not contain any untrue statement of
material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. 
  
 (dd) Each agreement between the Company, any Investment Adviser Subsidiary, or any other subsidiary of the Company on the one hand and any
Fund, Exempt Fund or private client on the other is a legal and valid obligation of the parties thereto, and none of the Company, any Investment Adviser Subsidiary or any other subsidiary of the Company is in breach or violation of or in default
under any such agreement which would individually or in the aggregate have a material adverse effect on the Company and its subsidiaries taken as a whole. 
  
 (ee) The offering contemplated by this Agreement will not constitute an “assignment” as defined in the 1940 Act and the Advisers
Act of any of the investment advisory contracts to which the Company or any of its Subsidiaries is a party. 
  
 2. Agreements to Sell and Purchase. The Company hereby agrees to sell to the several Initial Purchasers, and each Initial Purchaser, upon the basis
of the representations and warranties herein contained, but subject to the conditions hereinafter stated, agrees, severally and not jointly, to purchase from the Company the Securities set forth in Schedule I hereto opposite its name at a purchase
price of 98% of the principal amount thereof (the “Purchase Price”) plus accrued interest, if any, to the Closing Date. 
  
 The Company hereby agrees that, without the prior written consent of Morgan Stanley & Co. Incorporated on behalf of the Initial Purchasers, it will
not, during the period beginning on the date hereof and continuing to an including the 

  

 9 







 
date that is 60 days after the date of the Final Memorandum, (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any
option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of common stock or any securities convertible into or exercisable or exchangeable for class A
or class B common stock or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the class A or class B common stock, whether any such transaction described in
clause (i) or (ii) above is to be settled by delivery of class A or class B common stock or such other securities, in cash or otherwise. The foregoing sentence shall not apply to (A) the sale of the Securities under this Agreement, (B) the issuance
by the Company of any shares of class A or class B common stock upon the exercise of an option or warrant or the conversion of a security outstanding on the date hereof of which the Initial Purchasers have been advised, (C) the issuance of the
Underlying Securities upon conversion of the Securities in accordance with the terms of the Indenture or (D) the grant of options or stock under the Company’s stock incentive, dividend reinvestment or other employee ownership or benefit plans
is in effect on the date hereof. 
  
 3. Terms of Offering.
You have advised the Company that the Initial Purchasers will make an offering of the Securities purchased by the Initial Purchasers hereunder on the terms to be set forth in the Final Memorandum, as soon as practicable after this Agreement is
entered into as in your judgment is advisable. 
  
 4. Payment
and Delivery. Payment for the Securities shall be made to the Company in Federal or other funds immediately available in New York City against delivery of such Securities for the respective accounts of the several Initial Purchasers at 10:00
a.m., New York City time, on February 23, 2005, or at such other time on the same or such other date, not later than March 2, 2005, as shall be designated in writing by you. The time and date of such payment are hereinafter referred to as the
“Closing Date.” 
  
 The Securities shall be in
definitive form or global form, as specified by you, and registered in such names and in such denominations as you shall request in writing not later than one full business day prior to the Closing Date. The certificate evidencing the Securities
shall be delivered to you on the Closing Date for the respective accounts of the several Initial Purchasers, with any transfer taxes payable in connection with the transfer of the Securities to the Initial Purchasers duly paid, against payment of
the Purchase Price therefor plus accrued interest, if any, to the date of payment and delivery. 
  

 10 







 5. Conditions to the Initial Purchasers’ Obligations. The several obligations of the Initial
Purchasers to purchase and pay for the Securities on the Closing Date are subject to the following conditions: 
  
 (a) Subsequent to the execution and delivery of this Agreement and prior to the Closing Date there shall not have occurred: 
  
 (i) any downgrading, nor shall any notice have been given of
any intended or potential downgrading or of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded any of the Company’s securities by any “nationally recognized statistical
rating organization,” as such term is defined for purposes of Rule 436(g)(2) under the Securities Act; and 
  
 (ii) any change, or any development involving a prospective change, in the condition, financial or otherwise, or in the earnings, business
or operations of the Company and its subsidiaries, taken as a whole, from that set forth in the Preliminary Memorandum provided to prospective purchasers of the Securities that, in your judgment, is material and adverse and that makes it, in your
judgment, impracticable to market the Securities on the terms and in the manner contemplated in the Final Memorandum. 
  
 (b) The Initial Purchasers shall have received on the Closing Date a certificate, dated the Closing Date and signed by an executive
officer of the Company, to the effect set forth in Section 5(a)(i) and to the effect that the representations and warranties of the Company contained in this Agreement are true and correct as of the Closing Date and that the Company has complied
with all of the agreements and satisfied all of the conditions on its part to be performed or satisfied hereunder on or before the Closing Date. 
  
 The officer signing and delivering such certificate may rely upon the best of his or her knowledge as to proceedings threatened.

  
 (c) The Initial Purchasers shall have
received on the Closing Date an opinion of Skadden, Arps, Slate, Meagher & Flom LLP, special counsel for the Company, dated the Closing Date, to the effect set forth in Exhibit A. Such opinion shall be rendered to the Initial Purchasers at the
request of the Company and shall so state therein. 
  
 (d) The Initial Purchaser shall have received on the Closing Date an opinion of Robert P. Connolly, Managing Director, General Counsel and Secretary of the Company, dated the Closing Date, to the effect set forth in Exhibit B. Such opinion
shall be rendered to the Initial Purchasers at the request of the Company and shall so state therein. 
  

 11 







 (e) The Initial Purchasers shall have received on the Closing Date an opinion of Davis
Polk & Wardwell, counsel for the Initial Purchasers, dated the Closing Date, to the effect set forth in Exhibit B. 
  
 (f) The Initial Purchasers shall have received on each of the date hereof and the Closing Date a letter, dated the date hereof or the
Closing Date, as the case may be, in form and substance reasonably satisfactory to the Initial Purchasers, from Deloitte & Touche LLP, independent public accountants, containing statements and information of the type ordinarily included in
accountants’ “comfort letters” to underwriters with respect to the financial statements and certain financial information contained in or incorporated by reference into the Final Memorandum; provided that the letter delivered
on the Closing Date shall use a “cut-off date” not earlier than the date hereof. 
  
 (g) The “lock-up” agreements, each substantially in the form of Exhibit C hereto, between you and certain shareholders, officers
and directors of the Company listed on Schedule III hereto relating to sales and certain other dispositions of shares of common stock or certain other securities, delivered to you on or before the date hereof, shall be in full force and effect on
the Closing Date. 
  
 6. Covenants of the Company. In
further consideration of the agreements of the Initial Purchasers contained in this Agreement, the Company covenants with each Initial Purchaser as follows: 
  
 (a) To furnish to you in New York City, without charge, prior to 10:00 a.m. New York City time on the business day next succeeding the
date of this Agreement and during the period mentioned in Section 6(c), as many copies of the Final Memorandum, any documents incorporated by reference therein and any supplements and amendments thereto as you may reasonably request. 
  
 (b) Before amending or supplementing either Memorandum, to
furnish to you a copy of each such proposed amendment or supplement and not to use any such proposed amendment or supplement to which you reasonably object. 
  
 (c) If, during such period after the date hereof and prior to the date on which all of the Securities shall have been sold by the Initial
Purchasers, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Final Memorandum in order to make the statements therein, in the light of the circumstances when the Final Memorandum is delivered
to a purchaser, not misleading, or if, in the opinion of counsel for the Initial Purchasers, it is necessary to amend or supplement the Final Memorandum to comply with applicable law, 

  

 12 







 
forthwith to prepare and furnish, at its own expense, to the Initial Purchasers, either amendments or supplements to the Final Memorandum so that the
statements in the Final Memorandum as so amended or supplemented will not, in the light of the circumstances when the Final Memorandum is delivered to a purchaser, be misleading or so that the Final Memorandum, as amended or supplemented, will
comply with applicable law. 
  
 (d) To endeavor
to qualify the Securities for offer and sale under the securities or Blue Sky laws of such jurisdictions as you shall reasonably request. 
  
 (e) Whether or not the transactions contemplated in this Agreement are consummated or this Agreement is terminated (except pursuant to
Sections 9(i), (iii), (iv), or (v)), to pay or cause to be paid all expenses incident to the performance of its obligations under this Agreement, including: (i) the reasonable fees, disbursements and expenses of the Company’s counsel and the
Company’s accountants in connection with the issuance and sale of the Securities and all other fees or expenses in connection with the preparation of each Memorandum and all amendments and supplements thereto, including all printing costs
associated therewith, and the delivering of copies thereof to the Initial Purchasers, in the quantities herein above specified, (ii) all costs and expenses related to the transfer and delivery of the Securities to the Initial Purchasers, including
any transfer or other taxes payable thereon, (iii) all expenses in connection with the qualification of the Securities for offer and sale under state securities laws as provided in Section 6(d) hereof, including filing fees and the reasonable fees
and disbursements of counsel for the Initial Purchasers in connection with such qualification and in connection with the Blue Sky or legal investment memorandum, (iv) any fees charged by rating agencies for the rating of the Securities, (v) the fees
and expenses, if any, incurred in connection with the admission of the Securities for trading in PORTAL or any appropriate market system, (vi) the costs and charges of the Trustee and any transfer agent, registrar or depositary, (vii) the cost of
the preparation, issuance and delivery of the Securities, (viii) the document production charges and expenses associated with printing this Agreement and (ix) all other cost and expenses incident to the performance of the obligations of the Company
hereunder for which provision is not otherwise made in this Section. It is understood, however, that except as provided in this Section, Section 8, and the last paragraph of Section 10, the Initial Purchasers will pay all of their costs and
expenses, including fees and disbursements of their counsel, transfer taxes payable on resale of any of the Securities by them and any advertising expenses connected with any offers they may make. 
  

 13 







 (f) Neither the Company nor any Affiliate will sell, offer for sale or solicit offers to
buy or otherwise negotiate in respect of any security (as defined in the Securities Act) which could be integrated with the sale of the Securities in a manner which would require the registration under the Securities Act of the Securities.

  
 (g) Not to solicit any offer to buy or offer
or sell the Securities or the Underlying Securities by means of any form of general solicitation or general advertising (as those terms are used in Regulation D under the Securities Act) or in any manner involving a public offering within the
meaning of Section 4(2) of the Securities Act. 
  
 (h) While any of the Securities or the Underlying Securities remain “restricted securities” within the meaning of the Securities Act, to make available, upon request, to any seller of such Securities the information specified in
Rule 144A(d)(4) under the Securities Act, unless the Company is then subject to Section 13 or 15(d) of the Exchange Act. 
  
 (i) If requested by you, to use its best efforts to permit the Securities to be designated PORTAL securities in accordance with the rules
and regulations adopted by the National Association of Securities Dealers, Inc. relating to trading in the PORTAL Market. 
  
 (j) During the period of two years after the Closing Date the Company will not, and will not permit any of its affiliates (as defined in
Rule 144 under the Securities Act) to resell any of the Securities or the Underlying Securities which constitute “restricted securities” under Rule 144 that have been reacquired by any of them. 
  
 (k) Not to take any action prohibited by Regulation M under
the Exchange Act in connection with the distribution of the Securities contemplated hereby. 
  
 7. Offering of Securities; Restrictions on Transfer. Each Initial Purchaser, severally and not jointly, represents and warrants that such Initial Purchaser is a qualified institutional buyer as defined in Rule
144A under the Securities Act (a “QIB”). Each Initial Purchaser, severally and not jointly, agrees with the Company that (i) it will not solicit offers for, or offer or sell, such Securities by any form of general solicitation or
general advertising (as those terms are used in Regulation D under the Securities Act) or in any manner involving a public offering within the meaning of Section 4(2) of the Securities Act and (ii) it will solicit offers for such Securities only
from, and will offer such Securities only to, persons that it reasonably believes to be (A) in the case of offers inside the United States, QIBs that, in each case, in purchasing such Securities are deemed to have represented and agreed as provided
in the Final Memorandum under the caption “Transfer Restrictions”. 
  

 14 







 8. Indemnity and Contribution. (a) The Company agrees to indemnify and hold harmless each Initial
Purchaser, each person, if any, who controls any Initial Purchaser within the meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act, and each affiliate of any Initial Purchaser within the meaning of Rule 405 under the
Securities Act from and against any and all losses, claims, damages and liabilities (including, without limitation, any legal or other expenses reasonably incurred in connection with defending or investigating any such action or claim) caused by any
untrue statement or alleged untrue statement of a material fact contained in either Memorandum or any amendments or supplements thereto, or caused by any omission or alleged omission to state therein a material fact necessary to make the statements
therein in the light of the circumstances under which they were made not misleading, except insofar as such losses, claims, damages or liabilities are caused by any such untrue statement or omission or alleged untrue statement or omission based upon
information relating to any Initial Purchaser furnished to the Company in writing by such Initial Purchaser through you expressly for use therein; provided, however, that the foregoing indemnity agreement with respect to any
Preliminary Memorandum shall not inure to the benefit of any Initial Purchaser from whom the person asserting any such losses, claims, damages or liabilities purchased Securities, or any person controlling such Initial Purchaser, if a copy of the
Final Memorandum (as then amended or supplemented if the Company shall have furnished any amendments or supplements thereto) was not sent or given by or on behalf of such Initial Purchaser to such person, if required by law so to have been
delivered, at or prior to the written confirmation of the sale of the Securities to such person, and if the Final Memorandum (as so amended or supplemented) would have cured the defect giving rise to such losses, claims, damages or liabilities,
unless such failure is the result of noncompliance by the Company with Section 6(a) hereof. 
  
 (b) Each Initial Purchaser agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors, its officers and each person, if any, who controls the Company within the meaning of either
Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the foregoing indemnity from the Company to such Initial Purchaser, but only with reference to information relating to such Initial Purchaser furnished to the
Company in writing by such Initial Purchaser through you expressly for use in either Memorandum or any amendments or supplements thereto. 
  
 (c) In case any proceeding (including any governmental investigation) shall be instituted involving any person in respect of which indemnity may be sought
pursuant to Section 8(a) or 8(b), such person (the “indemnified party”) shall promptly notify the person against whom such indemnity may be sought (the “indemnifying party”) in writing and the indemnifying party,
upon request of the indemnified party, shall retain counsel reasonably satisfactory to the indemnified party to represent the indemnified party and any others the indemnifying party may designate in such proceeding and shall 

  

 15 







 
pay the reasonable fees and disbursements of such counsel related to such proceeding. In any such proceeding, any indemnified party shall have the right to
retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such indemnified party unless (i) the indemnifying party and the indemnified party shall have mutually agreed to the retention of such counsel or (ii) the
named parties to any such proceeding (including any impleaded parties) include both the indemnifying party and the indemnified party and representation of both parties by the same counsel would be inappropriate due to actual or potential differing
interests between them. It is understood that the indemnifying party shall not, in respect of the legal expenses of any indemnified party in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable
fees and expenses of more than one separate firm (in addition to any local counsel) for all such indemnified parties and that all such fees and expenses shall be reimbursed as they are incurred. Such firm shall be designated in writing by Morgan
Stanley & Co. Incorporated, in the case of parties indemnified pursuant to Section 8(a), and by the Company, in the case of parties indemnified pursuant to Section 8(b). The indemnifying party shall not be liable for any settlement of any
proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party from and against any loss or liability by reason of
such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by the second and
third sentences of this paragraph, the indemnifying party agrees that it shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 60 days after receipt by such
indemnifying party of the aforesaid request and (ii) such indemnifying party shall not have reimbursed the indemnified party in accordance with such request prior to the date of such settlement. No indemnifying party shall, without the prior written
consent of the indemnified party, effect any settlement of any pending or threatened proceeding in respect of which any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party, unless
such settlement includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such proceeding. 
  
 (d) To the extent the indemnification provided for in Section 8(a) or 8(b) is unavailable to an indemnified party or insufficient in respect of any
losses, claims, damages or liabilities referred to therein, then each indemnifying party under such paragraph, in lieu of indemnifying such indemnified party thereunder, shall contribute to the amount paid or payable by such indemnified party as a
result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Initial Purchasers on the other hand from the offering of the Securities
or (ii) if the allocation provided by clause 8(d)(i) above 

  

 16 







 
is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause 8(d)(i) above but
also the relative fault of the Company on the one hand and of the Initial Purchasers on the other hand in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant
equitable considerations. The relative benefits received by the Company on the one hand and the Initial Purchasers on the other hand in connection with the offering of the Securities shall be deemed to be in the same respective proportions as the
net proceeds from the offering of the Securities (before deducting expenses) received by the Company and the total discounts and commissions received by the Initial Purchasers, in each case as set forth in the Final Memorandum, bear to the aggregate
offering price of the Securities. The relative fault of the Company on the one hand and of the Initial Purchasers on the other hand shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material
fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or by the Initial Purchasers and the parties’ relative intent, knowledge, access to information and opportunity to correct or
prevent such statement or omission. 
  
 (e) The Company and the
Initial Purchasers agree that it would not be just or equitable if contribution pursuant to this Section 8(d) were determined by pro rata allocation (even if the Initial Purchasers were treated as one entity for such purpose) or by any other
method of allocation that does not take account of the equitable considerations referred to in Section 8(d). The amount paid or payable by an indemnified party as a result of the losses, claims, damages and liabilities referred to in Section 8(d)
shall be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions
of this Section 8, no Initial Purchaser shall be required to contribute any amount in excess of the amount by which the total price at which the Securities resold by it in the initial placement of such Securities were offered to investors exceeds
the amount of any damages that such Initial Purchaser has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The remedies provided for in this Section 8 are not exclusive and shall not limit any rights or remedies
which may otherwise be available to any indemnified party at law or in equity. 
  
 (f) The indemnity and contribution provisions contained in this Section 8 and the representations, warranties and other statements of the Company contained in this Agreement shall remain operative and in full force
and effect regardless of (i) any termination of this Agreement, (ii) any investigation made by or on behalf of any Initial Purchaser, any person controlling any Initial 

  

 17 







 
Purchaser or any affiliate of any Initial Purchaser or by or on behalf of the Company, its officers or directors or any person controlling the Company and
(iii) acceptance of and payment for any of the Securities. 
  
 9.
Termination. The Initial Purchasers may terminate this Agreement by notice given by you to the Company, if after the execution and delivery of this Agreement and prior to the Closing Date (i) trading generally shall have been suspended or
materially limited on, or by, as the case may be, the New York Stock Exchange or the Nasdaq National Market, (ii) trading of any securities of the Company shall have been suspended on any exchange or in any over–the–counter market, (iii) a
material disruption in securities settlement, payment or clearance services in the United States shall have occurred, (iv) any moratorium on commercial banking activities shall have been declared by Federal or New York State authorities or (v) there
shall have occurred any outbreak or escalation of hostilities, or any change in financial markets or any calamity or crisis that, in your judgment, is material and adverse and which, singly or together with any other event specified in this clause
(v), makes it, in your judgment, impracticable or inadvisable to proceed with the offer, sale or delivery of the Securities on the terms and in the manner contemplated in the Final Memorandum. 
  
 10. Effectiveness; Defaulting Purchasers. This Agreement shall become
effective upon the execution and delivery hereof by the parties hereto. 
  
 If, on the Closing Date any one or more of the Initial Purchasers shall fail or refuse to purchase Securities that it or they have agreed to purchase hereunder on such date, and the aggregate principal amount of Securities which such
defaulting Initial Purchaser or Initial Purchasers agreed but failed or refused to purchase is not more than one-tenth of the aggregate principal amount of Securities to be purchased on such date, the other Initial Purchasers shall be obligated
severally in the proportions that the principal amount of Securities set forth opposite their respective names in Schedule I bears to the aggregate principal amount of Securities set forth opposite the names of all such non-defaulting Initial
Purchasers, or in such other proportions as you may specify, to purchase the Securities which such defaulting Initial Purchaser or Initial Purchasers agreed but failed or refused to purchase on such date; provided that in no event shall the
principal amount of Securities that any Initial Purchaser has agreed to purchase pursuant to this Agreement be increased pursuant to this Section 10 by an amount in excess of one-ninth of such principal amount of Securities without the written
consent of such Initial Purchaser. If, on the Closing Date any Initial Purchaser or Initial Purchasers shall fail or refuse to purchase Securities which it or they have agreed to purchase hereunder on such date and the aggregate principal amount of
Securities with respect to which such default occurs is more than one-tenth of the aggregate principal amount of Securities to be purchased on such date, and arrangements satisfactory to you and the Company for the purchase of such Securities are
not made within 36 hours after 

  

 18 







 
such default, this Agreement shall terminate without liability on the part of any non–defaulting Initial Purchaser or of the Company. In any such case
either you or the Company shall have the right to postpone the Closing Date, but in no event for longer than seven days, in order that the required changes, if any, in the Final Memorandum or in any other documents or arrangements may be effected.

  
 If this Agreement shall be terminated by the Initial
Purchasers, or any of them, because of any failure or refusal on the part of the Company to comply with the terms or to fulfill any of the conditions of this Agreement, or if for any reason the Company shall be unable to perform its obligations
under this Agreement, the Company will reimburse the Initial Purchasers or such Initial Purchasers as have so terminated this Agreement with respect to themselves, severally, for all out-of-pocket expenses (including the fees and disbursements of
their counsel) reasonably incurred by such Initial Purchasers in connection with this agreement or the offering contemplated hereunder. 
  
 11. Counterparts. This Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the
signatures thereto and hereto were upon the same instrument. 
  
 12. Notices. All communications hereunder will be in writing and shall be deemed to have been duly given if mailed or transmitted by any standard form of telecommunication. Notice to the Initial Purchasers shall be directed c/o
Morgan Stanley & Co. Incorporated, 1585 Broadway, New York, New York 10036, Attention: Equity Capital Markets. Notices to the Company shall be directed to BlackRock, Inc., 40 East 52nd Street, New York, New York 10022, Attention: Robert Connolly. 
  
 13. Applicable Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of New York. 
  
 14. Headings. The headings of the sections of this Agreement have been
inserted for convenience of reference only and shall not be deemed a part of this Agreement. 
  

 19 








					
	 Very truly yours,

	
	 BLACKROCK, INC.

		
	By:	 	/s/    ROBERT P.
CONNOLLY        
	 	 	 Name:
	 	Robert P. Connolly
	 	 	 Title:
	 	Managing Director, General
	 	 	 	 	Counsel and Secretary


  









					
	 Accepted as of the date hereof

	
	 MORGAN STANLEY & CO. INCORPORATED

	
	 Acting severally on behalf of themselves and the several Initial Purchasers named in Schedule I hereto.

		
	By:	 	Morgan Stanley & Co. Incorporated
		
	By:	 	/s/    JOHN D.
TYREE        
	 	 	 Name:
	 	John D. Tyree
	 	 	 Title:
	 	Executive Director

  








  
 Schedule I 

 

				
	 Initial Purchasers

	  	$250,000,000 of
Securities to be
Purchased


	 Morgan Stanley & Co. Incorporated
	  	$	151,000,000
	 Citigroup Global Markets Inc.
	  	 	33,000,000
	 Merrill Lynch, Pierce, Fenner & Smith Incorporated
	  	 	33,000,000
	 UBS Securities LLC
	  	 	33,000,000
	 	  	
	

	 Total:
	  	$	250,000,000

  








  
 Schedule II 

 
 Subsidiaries 
  
 BlackRock Advisors, Inc. 
 BlackRock Financial Management, Inc. 
 BlackRock Institutional Management Corporation 
 BlackRock Funding, Inc. 
 BlackRock Funding International, Ltd. 
 BlackRock Investments, Inc. 
 Advanced Investment Management, Inc. 

BlackRock Overseas Investment Corp. 
 Risk Monitors, Inc. 
 Investment Technology, LLC 
 BlackRock (Japan), Inc. 
 BlackRock Capital Management, Inc. 
 BlackRock Asia Limited 
 BlackRock International, Ltd. 
 BlackRock Japan Holdings, Inc. 
 Nomura BlackRock Asset Management Co., Ltd. 
 BlackRock Japan Co., Ltd.

 BlackRock Advisors Singapore Pte. Ltd 
 BlackRock Portfolio
Holdings, Inc. 
 BlackRock HPB Management LLC 
 BlackRock
Portfolio Investments, LLC 
 BlackRock Absolute Return Partners (Offshore), Ltd. 
 BlackRock Funds Inflation Bond Portfolio 
 BlackRock Bond Allocation Target Shares Series C Portfolio 
 BlackRock Bond Allocation Target Shares Series S Portfolio 
 BlackRock Bond
Allocation Target Shares Series M Portfolio 
 SSRM Holdings, Inc. 
  








  
 Schedule III

  
 Lockups 
  
 William O. Albertini 
 Laurence D. Fink 
 Frank T. Nickell 
 Thomas H. O’Brien 
 David H. Komansky 
 James E.
Rohr 
 Ralph L. Schlosstein 
 Lawrence M. Wagner 
 William S. Demchak 
 Murry S. Gerber 
 James Grosfeld 
 William C. Mutterperl 
 Robert S. Kapito 
 Paul L. Audet 
 Robert S. Connolly 
 Linda Robinson 
 Sue Wagner (spouse of Lawrence M. Wagner) 
 The PNC Financial Services Group,
Inc. 
  








  
 EXHIBIT A 

 
 [OPINION OF SKADDEN, ARPS, SLATE, MEXGHER & FLOM LLP]

  

 A-1 







  
 EXHIBIT B 

 
 [OPINION OF IN-HOUSE COUNSEL] 
  

 B-1 







  
 EXHIBIT C 

 
 [OPINION OF DAVIS POLK & WARDWELL] 
  

 C-1